Quantumzyme Corp. is a shell company. The company is headquartered in San Diego, California. The company went IPO on 2017-04-25. The firm utilizes customer research to enhance enzyme activity, selectivity, and specificity by applying quantum mechanics, molecular modeling, and engineering approaches. The firm focuses on an approach to all chemical companies to harness the power of technology by simplifying complex chemistry and reducing the number of steps by implementing scientific rationale like quantum mechanics in biology. By integrating computational modeling with wet-lab validation, Quantumzyme delivers biocatalysis solutions that improve industrial sustainability. The firm focuses on solving complex chemistry problems across industry verticals ranging from Pharmaceutical, Fragrances, and Flavors. The Company’s Biocatalysis solution through engineered enzymes involves the application of scientific principles and techniques to modify and optimize the structure and function of enzymes for specific purposes.
QTZM stock price ended at $0.41 on 木曜日, after dropping 91.87%
On the latest trading day Feb 12, 2026, the stock price of QTZM fell by 91.87%, dropping from $4.99 to $0.41. During the session, the stock saw a volatility of 3471.43%, with prices oscillating between a daily low of $0.14 and a high of $5.00. On the latest trading day, the trading volume for QTZM rose by 347.3K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 475.5K shares were traded, with a market value of approximately $15.9M.